TY - JOUR
T1 - Cardiac Positron Emission Tomography-Magnetic Resonance Imaging
AU - Lau, Jeffrey M.C.
AU - Raptis, Demetrios A.
AU - Laforest, Richard
AU - Nensa, Felix
AU - Zheng, Jie
AU - Gropler, Robert J.
AU - Woodard, Pamela K.
N1 - Publisher Copyright:
© 2018 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Simultaneous acquisition positron emission tomography-magnetic resonance imaging (PET-MRI) has the ability to combine anatomic information derived from cardiac MRI with quantitative capabilities of cardiac PET and MRI and the promise of molecular imaging by specific PET tracers. This combination of cardiac PET and MRI delivers a robust and comprehensive clinical examination. It has the potential to assess various cardiovascular conditions, including assessment of myocardial ischemia, infarction, and function, as well as specific characterization of inflammatory and infiltrative heart diseases such as cardiac sarcoid and amyloid. It also offers fascinating possibilities in imaging other cardiovascular-related disease states, such as tumor imaging and vascular imaging. In this review, we begin with a general overview of the potentials of PET-MRI in cardiovascular imaging, followed by a discussion of the technical challenges unique to cardiovascular PET-MRI. We then discuss PET-MRI in various cardiovascular disease imaging applications. Potential limitations of PET-MRI and future directions are also considered.
AB - Simultaneous acquisition positron emission tomography-magnetic resonance imaging (PET-MRI) has the ability to combine anatomic information derived from cardiac MRI with quantitative capabilities of cardiac PET and MRI and the promise of molecular imaging by specific PET tracers. This combination of cardiac PET and MRI delivers a robust and comprehensive clinical examination. It has the potential to assess various cardiovascular conditions, including assessment of myocardial ischemia, infarction, and function, as well as specific characterization of inflammatory and infiltrative heart diseases such as cardiac sarcoid and amyloid. It also offers fascinating possibilities in imaging other cardiovascular-related disease states, such as tumor imaging and vascular imaging. In this review, we begin with a general overview of the potentials of PET-MRI in cardiovascular imaging, followed by a discussion of the technical challenges unique to cardiovascular PET-MRI. We then discuss PET-MRI in various cardiovascular disease imaging applications. Potential limitations of PET-MRI and future directions are also considered.
KW - Attenuation correction
KW - Cardiology
KW - Cardiomyopathy
KW - Cardiovascular imaging
KW - Motion correction
KW - Myocardial infarction
KW - Myocardial ischemia
KW - Positron emission tomography-magnetic resonance imaging
UR - http://www.scopus.com/inward/record.url?scp=85045936769&partnerID=8YFLogxK
U2 - 10.1097/RTI.0000000000000327
DO - 10.1097/RTI.0000000000000327
M3 - Review article
C2 - 29489584
AN - SCOPUS:85045936769
SN - 0883-5993
VL - 33
SP - 139
EP - 146
JO - Journal of Thoracic Imaging
JF - Journal of Thoracic Imaging
IS - 3
ER -